Platelet transcriptome analysis from small blood volumes

小血容量的血小板转录组分析

基本信息

项目摘要

DESCRIPTION (provided by applicant): Human blood platelets play critical roles in normal hemostatic processes and pathologic conditions such as thrombosis, vascular remodeling, inflammation, and wound repair. Generated as cytoplasmic buds from precursor bone marrow megakaryocytes, platelets are enucleate and lack nuclear DNA, although they retain megakaryocyte-derived mRNAs. Towards the goal of defining the molecular anatomy of the platelet transcriptome, we have adapted complementary techniques of microarray and serial analysis of gene expression (SAGE) for genetic profiling of highly purified human blood platelets (Blood 101:2285-2293), and demonstrated the potential applicability of this approach for the molecular analysis of a rare platelet disorder (essential thrombocythemia). While these observations established the initial proof-of-principle supporting this research direction, current platelet isolation procedures require plateletpheresis and relatively cumbersome purification methods for optimal determinations, limiting wider applicability. During the tenure of this grant, we propose to develop a miniaturized system for high-throughput platelet transcriptome analysis. In specific aim 1, we will adapt and develop mechanical shear as an efficient methodology for separation of ultra-pure platelets from whole blood (1 mL), followed by mRNA isolation and representative transcript amplification uniquely adapted for small RNA yields. In specific aim 2, we will develop a customized platelet cDNA chip for confirmatory studies of amplified platelet mRNA fidelity as established by microarray analysis. If successful, this project will develop the appropriate infrastructure and methodologies for more comprehensive profiling of larger data sets, a major long-term goal of this area of investigation. Given the importance of platelets in cardiovascular disease and stroke, these studies will have considerable implications for novel gene discovery, and for molecular diagnostics targeted at large patient populations.
描述(申请人提供):人的血小板在正常的止血过程和病理状态中起着关键作用,如血栓形成、血管重塑、炎症和伤口修复。血小板是由前体骨髓巨核细胞产生的细胞质芽,是去核的,没有核DNA,尽管它们保留了来自巨核细胞的mRNAs。为了确定血小板转录组的分子解剖学的目标,我们采用了互补的微阵列和基因表达序列分析(SAGE)技术来对高纯度的人血小板(血液101:2285-2293)进行遗传图谱分析,并证明了这种方法在一种罕见的血小板疾病(特发性血小板增多症)的分子分析中的潜在适用性。虽然这些观察确立了支持这一研究方向的初步原则证明,但目前的血小板分离程序需要血小板采集和相对繁琐的纯化方法才能获得最佳检测结果,从而限制了更广泛的适用性。在这笔赠款的任期内,我们建议开发一种用于高通量血小板转录组分析的微型系统。在具体目标1中,我们将采用和开发机械剪切法作为从全血(1毫升)中分离超纯血小板的有效方法,然后进行mRNA分离和代表性转录扩增,以获得独特的小RNA产量。在特定的目标2中,我们将开发一种定制的血小板基因芯片,用于通过微阵列分析建立的扩增的血小板mRNA保真度的确证研究。如果成功,该项目将开发适当的基础设施和方法,以便更全面地分析更大的数据集,这是这一调查领域的一个主要长期目标。鉴于血小板在心血管疾病和中风中的重要性,这些研究将对新的基因发现和针对大量患者群体的分子诊断具有相当大的意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dmitri V GNATENKO其他文献

Dmitri V GNATENKO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dmitri V GNATENKO', 18)}}的其他基金

Detection of fetal platelets in maternal blood using platelet RNA biomarkers.
使用血小板 RNA 生物标志物检测母血中的胎儿血小板。
  • 批准号:
    9905924
  • 财政年份:
    2020
  • 资助金额:
    $ 20.69万
  • 项目类别:
HLS-Detection of RNA biomarkers in individual platelets
HLS-检测个体血小板中的 RNA 生物标志物
  • 批准号:
    9341731
  • 财政年份:
    2017
  • 资助金额:
    $ 20.69万
  • 项目类别:
Diagnostic Assay for Thrombocytosis
血小板增多症的诊​​断测定
  • 批准号:
    7999771
  • 财政年份:
    2010
  • 资助金额:
    $ 20.69万
  • 项目类别:
Platelet transcriptome analysis from small blood volumes
小血容量的血小板转录组分析
  • 批准号:
    6763729
  • 财政年份:
    2004
  • 资助金额:
    $ 20.69万
  • 项目类别:

相似海外基金

Non-contact blood volume pulse measurement based on multidimensional signal processing
基于多维信号处理的非接触式血容量脉搏测量
  • 批准号:
    23KJ1961
  • 财政年份:
    2023
  • 资助金额:
    $ 20.69万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
A Near-Patient, Low Blood Volume Platform for Rapid Comprehensive Evaluation of Coagulation in Trauma Patients
用于快速综合评估创伤患者凝血功能的近患者低血容量平台
  • 批准号:
    10697216
  • 财政年份:
    2023
  • 资助金额:
    $ 20.69万
  • 项目类别:
Development of a rapid, scalable, and deployable point-of-care blood volume diagnostic for monitoring postpartum and trauma-related hemorrhage
开发快速、可扩展且可部署的护理点血容量诊断,用于监测产后和创伤相关出血
  • 批准号:
    10603819
  • 财政年份:
    2023
  • 资助金额:
    $ 20.69万
  • 项目类别:
Establishment of a novel optical method for measuring cerebral blood flow and blood volume
一种新型光学测量脑血流量和血容量方法的建立
  • 批准号:
    23K03873
  • 财政年份:
    2023
  • 资助金额:
    $ 20.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The effects of an intraoperative targeted low-splanchnic blood volume restrictive fluid management strategy compared to a liberal one on postoperative outcomes in liver transplantation - the REFIL (REstrictive Fluid management In Liver transplantation) pi
术中目标低内脏血容量限制性液体管理策略与自由性液体管理策略相比对肝移植术后结果的影响 - REFIL(肝移植中的限制性液体管理)pi
  • 批准号:
    461194
  • 财政年份:
    2022
  • 资助金额:
    $ 20.69万
  • 项目类别:
    Operating Grants
Understanding the role of blood volume as a determinant of aerobic and anaerobic metabolism
了解血容量作为有氧和无氧代谢决定因素的作用
  • 批准号:
    567896-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 20.69万
  • 项目类别:
    Postdoctoral Fellowships
A Low Blood Volume Platform for Recurrent Anticoagulation and Kidney Monitoring during Continuous Renal Replacement Therapy in Critically Ill Children
危重儿童连续肾脏替代治疗期间反复抗凝和肾脏监测的低血容量平台
  • 批准号:
    10383224
  • 财政年份:
    2022
  • 资助金额:
    $ 20.69万
  • 项目类别:
A Low Blood Volume Platform for Recurrent Anticoagulation and Kidney Monitoring during Continuous Renal Replacement Therapy in Critically Ill Children
危重儿童连续肾脏替代治疗期间反复抗凝和肾脏监测的低血容量平台
  • 批准号:
    10820748
  • 财政年份:
    2022
  • 资助金额:
    $ 20.69万
  • 项目类别:
Development and validation of precision blood volume diagnostic and decision support device for acute decompensated heart failure
急性失代偿性心力衰竭精准血容量诊断和决策支持装置的开发和验证
  • 批准号:
    10474788
  • 财政年份:
    2021
  • 资助金额:
    $ 20.69万
  • 项目类别:
In vivo Fractional Blood Volume: Contributions to Renal BOLD MRI.
体内血容量分数:对肾脏 BOLD MRI 的贡献。
  • 批准号:
    10395426
  • 财政年份:
    2021
  • 资助金额:
    $ 20.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了